Formulary positioning and benefit design frequently determine utilization, as weak placement or reimbursement dynamics can ...
Integrated direct-to-patient models use AI-enabled eBenefits/eVerification plus real-time claims adjudication to surface ...
Supreme Court inaction leaves intact lower-court rulings rejecting takings and compelled-speech theories against “fair price” designations in Medicare price negotiation. Courts emphasized ...
Jeremy Richardson explains how direct-to-patient models increase drug pricing transparency and demonstrate value.
Record drug shortages (≥216 active in the US in 2025) expose limited end-to-end visibility, motivating AI-driven early risk detection and coordinated mitigation across fragmented networks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results